Dilaudid: Difference between revisions
(Dilaudid administration) |
No edit summary |
||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Oral: 2-4 mg PO q4-6h PRN | |||
*IV: 0.2-1 mg IV q2-3h PRN | |||
*IM: 1-2 mg IM q2-3h PRN (not recommended secondary to variable absorption) | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 00:32, 12 May 2016
Administration
- Type: Opiods
- Routes of Administration: Oral, IM, IV, PCA
- Common Trade Names: Hydromorphone
Adult Dosing
- Oral: 2-4 mg PO q4-6h PRN
- IV: 0.2-1 mg IV q2-3h PRN
- IM: 1-2 mg IM q2-3h PRN (not recommended secondary to variable absorption)
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: